Clinicopathological study of premalignant and malignant lesions of cervix along with apoptotic index and Ki-67 expression

Bhagyalakshmi Atla, Uma Prasad, Saraswathi Samantra, Venkata Satya Kartheek Botta, Naresh Dasari, Glen Christopher Changala


Background: Cervical cancer is known to have a good response to radiotherapy. The response and prognosis are dependent on the level of apoptosis. Pap smear and histopathology are cost-effective methods in diagnosing premalignant and malignant lesions of cervix but not accurate in classifying and estimating the progression of the disease, especially in premalignant lesions. Therefore this study was undertaken to know the role of Ki-67 expression and apoptotic index in classifying accurately the premalignant lesions for better management.

Methods: The study included 540 cases diagnosed histologically as cervical intraepithelial neoplasia or carcinoma. The apoptotic index is calculated for all the 540 cases using light microscopy on Haematoxylin and Eosin stained sections. Ki-67 immunohistochemical staining was done for 100 cervical biopsies. Ki-67 expression was graded and the Ki-67 labelling index was calculated. Statistical evaluation was done using the unpaired t-test.

Results: The Apoptotic index increased with increasing grade of dysplasia. There is a significant difference in the mean apoptotic index between premalignant and malignant lesions of the cervix. The ki-67 index increased with increasing grade of dysplasia. There is a significant difference in the mean Ki-67 index between premalignant and malignant lesions of the cervix.

Conclusions: Apoptotic index and proliferative indices have been found useful in distinguishing between premalignant and malignant lesions of the cervix and gives an idea about the proliferative activity of the tumour for better management of the patient and to determine prognosis.


Apoptotic index, Cervical intraepithelial neoplasia, Ki-67 labelling index

Full Text:



Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, et al. ICO/IARC information centre on HPV and cancer (HPV Information Centre), human papillomavirus and related diseases in India. Available at: reports/XWX.pdf. Accessed on 20 January 2020.

McCluggage WG, Walsh MY, Thornton CM, Hamilton PW, Date A, Caughley LM, et al. Inter and intraobserver variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system. British Journal of Obstetrics and Gynaecology. 1998;105: 206-10.

Zummeren M, Annemiek L, Wieke KW, Maaike BCG; David J. Three-tiered score for Ki-67 and p16ink4a improves accuracy and reproducibility of grading CIN lesions. Journal of Clinical Pathology. 2018;71(11):981-8.

Dlamini Z, Mbita Z, Zungu M. Genealogy, expression and molecular mechanisms in apoptosis. Pharmacol Ther. 2004;101:1-15.

Gogoi PK, Borgohain M, Sonowal R. Ki-67 expression and apoptotic index in premalignant and malignant lesions of uterine cervix. International Journal of Contemporary Medical Research. 2016; 3(11):3401-5.

Gupta K, Alam K, Maheshwari V, Khan R, Sharma R. Apoptotic Index and MIB-1 Antibody Expression in Premalignant and Malignant Lesions of Uterine Cervix. Gynecol Obstet. 2013;3(5):105-9.

Mehrotra A, Goel MM. Assessment of monoclonal antibody MIB-1 labeling indices in cervical intraepithelial lesions of the uterine cervix in paraffin section. J Obstet Gynecol India. 2008;58(4):94-9.

Chauhan R, Verma N, Sharma SP, Bhargava R, Singh P. Role of apoptotic index, mitotic index and MIB-1 antibody expression as biomarkers in preneoplastic and neoplastic lesions of uterine cervix. Int J Res Med Sci. 2016;4:2093100.

Nam EJ, Kim JW, Hong JW, Jang HS, Lee SY. Expression of the p16INK4a and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection. J Gynecol Oncol. 2008;19:162168.

Okwi AL, Wandabwa J, Okoth A, Emmanuel J. Prevalence of cancerous and pre-malignant lesions of cervical cancer and their association with risk factors as seen among women in the regions of Ugandao. Journal of Clinical and Laboratory Medicine. 2017; 2(1):1-7.

Jain R, Walker R, Jain L, Jatav JK. Evaluation of cervical lesions: a prospective study. International Journal of Scientific Study. 2016;3(1):63-9.

Keating JT, Cviko A, Riethdorf S. Ki-67, cyclin E, and p16INK4 are complementary surrogate biomarkers for human papillomavirus-related cervical neoplasia. Am J Surg Pathol. 2001;25:884-91.

Ivo J, Zenon P, Ivana K, Mihovil B, Gordana J. Expression and prognostic value of the Ki-67 in Wilms’ tumor: experience with 48 cases. Pediatric Surgery International. 2010;26(5):487-93.

Eduardo CE, Cavaliere MJ, Calore P, Dias MN, De Souza S, Santos RP, et al. Expression of Ki-67 in cervical epithelial cells in preneoplastic lesions of patients with AIDS. Gynecologic and Obstetric Investigation. 2001;51(1):51-4.

Sahebali S, Depuydt CE, Segers K, Vereecken AJ, Van Marck E. Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool?. Journal of Clinical Pathology. 2013;56(9): 681-6.

Mysorekar VV, David S, Rao SG. Proliferative and Apoptotic Indices in Squamous Epithelial Lesions of the Cervix. Bahrain Medical Bulletin. 2008;30(4):65-73.

Bhardwaj S, Wani FA. Evaluating the Importance of Apoptotic Index, Mitotic Index and Turnover Index in Premalignant and Malignant Lesions of cervix. Open Journal of Pathology. 2015;5:29-37.

Dey P, Das R, Sabuddin. Correlations between Apoptotic and Proliferative Indices in Cervical Intraepithelial. Indian Journal of Pathology and Microbiology. 2000;43:271-5.